Summary
Sergei Grebenyuk is a founder and CEO with 11 years of cross-disciplinary experience at the intersection of biophysics, software engineering, and drug-discovery hardware. He built research-grade imaging and live tissue perfusion systems, developed hard real-time and data-engineering software, and translated those capabilities into a synthetic vascularization platform for organoids now aimed at drug discovery. His background spans hands-on lab neuroscience at RIKEN and the University of Utah to venture due diligence and pharma/IT market analysis, giving him rare fluency in both scientific rigor and commercial strategy. Holding a PhD in Biophysics and an MSCS in Computer Engineering, he combines machine-learning/data analysis skills with product-minded engineering to bridge bench innovations and scalable biotech tools. An entrepreneur based in Leuven, he’s notable for pairing novel microfabrication and continuous readout technologies with pragmatic business plans.
11 years of coding experience
9 years of employment as a software developer
Ph.D., Biophysics, Ph.D., Biophysics at Bogomoletz Institute of Physiology
Igor Sikorsky Kyiv Polytechnic Institute
English, Ukrainian